Phase 1-2, prospective, randomised, double blind, placebo-controlled, dose escalation, parallel-group study to test the efficacy and safety of homatropine methylbromide oral suspension on selected climacteric symptoms and quality of life in menopausal women not receiving hormonal replacement therapy.
Phase of Trial: Phase I/II
Latest Information Update: 01 Sep 2012
At a glance
- Drugs Homatropine methylbromide (Primary)
- Indications Hot flashes
- Focus Adverse reactions
- 01 Sep 2012 New trial record